Corrigendum to: 'Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target' [J Hepatol 2021 (74) 1155-1166].
J Hepatol
; 76(5): 1242-1243, 2022 May.
Article
in En
| MEDLINE
| ID: mdl-35221117
Full text:
1
Database:
MEDLINE
Language:
En
Year:
2022
Type:
Article